Bearish Bets: 3 Stocks You Definitely Should Think About Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

This Promising Biotech Is Just Right for a Covered-Call Play

Let me show you how to trade Axsome Therapeutics, for potentially awesome returns.

Is Bitcoin's Decline Foreshadowing Further Nasdaq Weakness?

Technical analysts often look for stocks or indexes for subtle hints on ones leading the pack.

How to Buy a Dip Without Buying a Dud

Snapping up a stock on a pullback can be a winning strategy for traders, but you have to know how to do it.

FSI Weekly Roadmap: Tough September Start, but Broader Outlook Is Constructive

Potentially positive catalysts are expected next week, notably the latest CPI numbers. Plus our latest view on Apple.

3 Monthly Dividend Stocks With Eye-Popping Yields for Income Investors

By paying monthly, these names are attractive from a reliable and regular income flow perspective.

Inflation Outlook, Global Woes Put Renewed Pressure on Stocks

Bad news out of China and Europe, higher oil prices and rising bond yields appeared to justify the expected September slump.

The Smart Money Might Finally Put Their Money Where Their Mouths Are on Oil

The spread between the market sentiment of industry insiders and the net long futures position held in crude oil is unsustainably wide.

Kenvue, the J&J Healthcare Spinoff, Has Disappointed Investors

The company went public in May. Let's see what the charts tell us.

Can Intel Continue to Grind Higher or Should We Nail Down Profits?

I've got an answer for you.